From Genome Analysis Wiki
Jump to navigationJump to search
9 bytes added
, 09:37, 30 September 2011
Line 105: |
Line 105: |
| |W. Zheng | | |W. Zheng |
| |- | | |- |
− | |BMI Extremes | + | |Pfizer – MGH – Broad |
− | |BMI | + | |Type 2 diabetes extremes of risk |
| + | |European |
| + | |182 |
| + | |D. Altshuler |
| + | |- |
| + | |Lipid Extremes |
| + | |Lipid Extremes |
| |European | | |European |
− | |46 | + | |131 |
− | |J. Hirschhorn | + | |S. Kathiresan and D. Rader |
| |- | | |- |
− | |I2B2 - Major Depression | + | |Int’l HIV Controllers Study |
− | |Major Depression, Major Depressive Disorder | + | |HIV Controllers |
| |European | | |European |
− | |50 | + | |121 |
− | |R. Perlis and J. Smoller | + | |P. De Bakker |
| |- | | |- |
| |SAEC DILI (merged w/Autism tranches) | | |SAEC DILI (merged w/Autism tranches) |
Line 123: |
Line 129: |
| |M. Daly and A. Holden | | |M. Daly and A. Holden |
| |- | | |- |
− | |Int’l HIV Controllers Study | + | |I2B2 - Major Depression |
− | |HIV Controllers | + | |Major Depression, Major Depressive Disorder |
| |European | | |European |
− | |121 | + | |50 |
− | |P. De Bakker | + | |R. Perlis and J. Smoller |
| |- | | |- |
− | |Lipid Extremes | + | |BMI Extremes |
− | |Lipid Extremes | + | |BMI Extremes |
| |European | | |European |
− | |131 | + | |46 |
− | |S. Kathiresan and D. Rader | + | |J. Hirschhorn |
− | |-
| |
− | |Pfizer – MGH – Broad
| |
− | |Type 2 diabetes extremes of risk
| |
− | |European
| |
− | |182
| |
− | |D. Altshuler
| |
| |} | | |} |
| | | |